1. Ultra-early thrombolytic drugs: used in patients with ultra-early cerebral infarction (within 6 hours of onset), including urokinase and recombinant tissue plasminogen activator, with high bleeding risk. After evaluation by professional doctors, the above drugs are applied intravenously to suitable patients to restore blood supply to brain tissue and preserve brain cells.
2. Antiplatelet drugs: At present, antiplatelet therapy is a common strategy to prevent and treat thrombotic diseases. The commonly used antiplatelet drugs are aspirin and clopidogrel. Patients without thrombolytic therapy should be treated with antiplatelet drugs as soon as possible.
3. Brain protective drugs: Commonly used drugs include edaravone, citicoline, oxiracetam, etc., which can relieve ischemic brain injury by scavenging free radicals and blocking excitatory amino acid receptors, and play a role in brain protection.
4. Statins: Commonly used drugs such as atorvastatin and fluvastatin can reduce blood lipids, stabilize plaques and improve the prognosis of patients with cerebral infarction.
5. Anticoagulant drugs: including low molecular weight heparin and warfarin. Can be used for treating high-level patients with thrombotic diseases such as hypercoagulability or atrial fibrillation.
6. Other drugs: such as defibrase drugs, vasodilators and some traditional Chinese medicine preparations. , can be selected according to the patient's condition.
It can be seen that there are many drugs to treat cerebral infarction, and the best treatment method should be to choose appropriate drugs under the guidance of professional doctors to achieve the best clinical effect.